KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Cost of Revenue (2016 - 2026)

Boston Scientific's Cost of Revenue history spans 18 years, with the latest figure at $1.6 billion for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 11257.14% to $1.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $3.2 billion, a 139.88% increase, with the full-year FY2025 number at $6.2 billion, up 18751.52% from a year prior.
  • Cost of Revenue hit $1.6 billion in Q1 2026 for Boston Scientific, down from $1.6 billion in the prior quarter.
  • Over the last five years, Cost of Revenue for BSX hit a ceiling of $4.3 billion in Q4 2023 and a floor of -$2.9 billion in Q4 2022.
  • Historically, Cost of Revenue has averaged $656.8 million across 5 years, with a median of $955.0 million in 2022.
  • Biggest five-year swings in Cost of Revenue: tumbled 398.15% in 2022 and later surged 17766.67% in 2025.
  • Tracing BSX's Cost of Revenue over 5 years: stood at -$2.9 billion in 2022, then skyrocketed by 248.72% to $4.3 billion in 2023, then tumbled by 99.79% to $9.0 million in 2024, then surged by 17766.67% to $1.6 billion in 2025, then decreased by 1.12% to $1.6 billion in 2026.
  • Business Quant data shows Cost of Revenue for BSX at $1.6 billion in Q1 2026, $1.6 billion in Q4 2025, and $12.0 million in Q3 2025.